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doi:10.1016/j.ejvs.2008.06.027Abstract Objective: To evaluate outcome and patency predicting factors of kissingstent
treatment for aorto iliac occlusive disease (AIOD).
Methods: Patients treated with kissingstents for AOID between 1995 and 2004 at a tertiary
referral center were identified through local databases. Chart review and preoperative images
were used for TASC and Fontaine classification. Follow-up consisted of clinical exams, ABI and/
or duplex. Patency rates were estimated by Kaplan-Meier analysis, and Cox multivariate
regression was used to determine factors associated with patency.
Results: 173 consecutive patients (46% male, mean 64 years) were identified. TASC distribution
was: A 15%, B 34%, C 10%, D 41%. Mean follow-up was 36 months (range: 1e144). 30-day
mortality was 1% (2 patients), and 1-year survival was 91% (157 patients). 2 patients underwent
late, open conversion and 13 patients suffered minor puncture site complications. Primary,
assisted primary and secondary patency was: 97%, 99% and 100%, and 83%, 90% and 95% at
twelve and 36 months respectively. There was no significant difference in patency between
the TASC groups. Patency was significantly worse for patients in Fontaine class III.
Conclusions: Aortoiliac kissing stents is a valid alternative to open repair for TASC A-D lesions.
The procedure has low mortality and morbidity and good patency at 3 years.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
AIOD has traditionally been treated with open surgery,
commonly with aorto-bifemoral bypass. Surgical treatmentMD, Vascular Center, Malmo¨
Ing 59 UMAS, 205 02 Malmo¨,
40338097.
med.lu.se (K. Bjo¨rses).
ty for Vascular Surgery. Publisheof AIOD is burdened with a peri-operative mortality of 3e5%
and morbidity of 8e13%.1 Endovascular treatment reduces
mortality and both rate and severity of complications2e4
and has rapidly replaced open surgery in mild to moderate
lesions, defined as TASC class A and B.5 There are, however,
still controversies whether endovascular treatment is
optimal for more advanced lesions such as severely calci-
fied long segments or extensive occlusions of the iliac
arteries and/or the entire aortic bifurcation, defined asd by Elsevier Ltd. All rights reserved.
Table 1 TASC 2000 classification of aorto-iliac lesions
Type A
lesions:  Unilateral or bilateral stenoses of CIA
 Unilateral or bilateral short ( 3 cm)
stenosis of EIA
Type B
lesions: Short ( 3 cm) stenosis of infrarenal aorta
Unilateral CIA occlusion
Single or multiple stenosis totaling 3e10 cm
involving EIA, not extending to the CFA
Unilateral EIA occlusion, not invoving the
the origins of internal iliac or CFA
Type C
lesions: Bilateral CIA occlusions
Bilateral EIA stenoses 3e10 cm long, not
extending into the CFA
Unilateral EIA stenosis extending into the CFA
Unilateral EIA occlusion that involves the
origins of internal iliac and/or CFA
Heavily calcified unilateral EIA occlusion
with or without involvement of origins of
internal iliac and/or CFA
Type D
lesions: Infrarenal aorto-iliac occlusion
Diffuse disease involving the aorta and both
iliac arteries requiring treatment
Diffuse multiple stenoses involving the
unilateral CIA. EIA and CFA
Unilateral occlusions of both CIA and EIA
Bilateral occlusions of EIA
Iliac stenoses in patients with AAA requiring
treatment and not amendable to endograft
placement or other lesions requiring open
aortic or iliac surgery
CIA: common iliac artery, EIA: external iliac artery, CFA:
common femoral artery, AAA: abdominal aortic aneurysm.
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the TASC committee still advocate surgical treatment for
class C and D lesions.5
There are several published single center series of
kissingstents in the aortic bifurcation, none of which give
a clear-cut answer to whether TASC classification predicts
outcome.6e16
At our tertiary vascular referral center, endovascular
treatment has been the primary treatment option for AOID
since 1995, during this period of time only 16 patients
underwent primary treatment with OR (aortobifemoral
bypass) on this indication. The aim of this study was to
analyze outcome after kissingstent placement and to
determine if TASC classification or other factors, such as
stent type, affects outcome for our patients.
Patients and Methods
Patients treated with kissingstents in the aortic bifurcation
between 1995 and 2004 in Malmo¨ were identified through
local databases. All intraoperative angiographies were
reviewed for TASC classification (the original TASC classifi-
cation from 2000 was used, Table 1). Operative notes were
analyzed for number, make and size of stents inserted in
the distal aorta, common and external iliac arteries.
Patients’ charts were analysed for demographic data,
complications and follow-up. Their pre-interventional
symptoms were graded according to the Fontaine
classification.5,17
Technique
All procedures were performed in a dedicated angiosuite
with a fixed c-arm system (Siemens, www.medical.siemens.
com). All patients were treated percutaneously through
bilateral common femoral arterial (CFA) punctures, in
most cases with six or seven French introducers. The CFA
punctures were performed under fluoroscopic guidance,
frequently with micro-puncture technique and contrast
injections to confirm a correct location of the puncture.
If necessary (patients with bilateral occlusions of common
iliac arteries and/or occlusion of distal aorta), brachial
access was used to facilitate the procedure. Patients with
disease extending into the CFA requiring simultaneous
surgical treatment were excluded from this study. All
patients were taking anti-platelet medication (75 mg
acetylsalicylate or clopidogrel daily) and during interven-
tion 50e100 IU/kg bodyweight of heparin (Heparin Leo,
Leo Pharma AB, www.leo.se) was administered intra arteri-
ally. Stenoses were passed intraluminally and occlusions
recanalized subintimally with a 0.0035’’ hydrophilic guide-
wire (Terumo, www.terumomedical.com). All kissingstents
were deployed with the proximal end in the aorta one e
two cm above the native aortic bifurcation. Choice of stent
was at the interventionist’s discretion. Self-expanding
nitinol stents were the primary choice in long tortuous
lesions if not heavily calcified, in which case balloon
expandable stents or occasionally covered stents were
used. All self-expanding stents were post dilated to the
nominal vessel diameter, measured on the pre-treatment
angiogram. Technical success was defined as less than 30%residual stenosis and/or mean pressure gradient of five
mmHg or less across the treated segments. After interven-
tion all patients remained in hospital overnight, and received
lowmolecular weight heparin subcutaneously (40 mg enoxa-
parin sodium, Sanofi-Aventis, www.sanofi-aventis.com). The
patients continued with their ordinary anti-platelet medica-
tion with addition of statins after discharge from hospital.
Follow-up
The standardized follow-up (FU) at the clinic consisted of
clinical examination including ankle-brachial index (ABI)
measurement one month and one year after intervention.
After this patients were informed to return if symptoms
recurred. An additional FU was performed between Oct
2005 and Feb 2007, when all patients alive and traceable
were offered a clinical examination, ABI measurement and
an ultrasound duplex scan. The majority of patients
accepted. (Fig. 1) Since the distal aorta and common iliac
arteries were often difficult to visualize with ultrasound
duplex, the evaluation of the suprainguinal arteries was
made by flow measurements and Doppler Pulse Wave
recordings in the common femoral artery bilaterally.18e20
If the examinations indicated a restenosis or occlusion
suprainguinally, the patient was offered a CT scan. If the
Standardized FU:
ABI and clinical exam at
30 days and 1 year
post procedure  
Oct 2004 - Jan 2006
patients were invited to a late
FU with duplex examination: 
38 patients (22     )
were dead
(11 d – 8 years postprocedure)
105 patients (61    )
accepted and were
examined with duplex
8 patients (5     )
were examined
with CT, MRI or
DSA
22 patients (12     )
were lost to the late FU
(refused, lived too peripheral
to hospital, etc)
some FU hospital chart
records available in all  
underwent the late FUwith
duplex (or CT, MRI, DSA)
5 patient died after late FU
113 patients (66     )
173 patients
treated with kissingstents
1995-2004  
Figure 1 Flowchart with FU details of the 173 patient treated with kissingstents in the aortic bifurcation.
426 K. Bjo¨rses et al.CT confirmed stenosed or occluded stents, or progression of
the disease proximally or distally of the treated region, the
patients were offered a re-intervention to maintain or
restore patency.
Patency was defined according to SVS-ISVS17 (primary
patency: open stents without any re-intervention, assisted
secondary patency: open stents after re-intervention due
to stenosis of the stents or adjacent vessel segments,
secondary patency: open stents after re-intervention due
to stent occlusion) and defined per patient, and not per
limb. All calculations are based on the outcome of the kis-
singstents. Other stents placed in the suprainguinal
segments at the intervention were registered and further
defined according to the status of the complete treated
segments.
The local clinical board approved the study protocol.
Statistics
Statistical significance was defined as p< 0.05. Categorical
data was analyzed with Chi square and Fishers exact test.
Comparisons of ABI and Fontaine Classification in patients
pre- and post-procedure were made with Wilcoxon´s tests.
Mann-Whitney U test was used for comparing groups with
nonparametric continuous data. Patency rates were deter-
mined with Kaplan-Meier and life table analysis. Coxregression was used to analyze failure rate yielded relative
risks with a 95% confidence interval. A second analysis
included all potential determinants in the same model.
SPSS for windows version 13.0 (SPSS Inc, Chicago, Illinois,
www.spss.com.) was used for all statistical analysis.
Results
173 consecutive patients (46% men, mean age 64.2 years)
were identified. The majority of the patients (70%) were
treated in the later part of the study period (2001e2004).
Mean follow-up (FU) time was 36 months (1e144 months, SD
27.5). FU details are presented in the flowchart (Fig. 1).
Demographic data are summarized in Table 2. 72% of the
patients were claudicants (Fontaine II), 27% presented
with critical limb ischemia (CLI), Fontaine III-IV. 38% of
the patients had bilateral symptoms. The only asymptom-
atic patient (Fontaine I) had renal insufficiency, and was
treated to optimize suprainguinal circulation before renal
transplantation.
Procedure details
Thirty patients (17%) received stents in the infrarenal
aorta; eleven of these were also recanalized because of
Table 2 Demographic data of 173 patients treated with
kissingstents in the aortic bifurcation
Clinical characteristics N (%)
Gender:
Male 79 (45,7%)
Female 94 (54,3%)
Risk factors:
Smoking 101 (58,4%)
Coronary heart disease 45 (26,0%)
Hypertension 78 (45,1%)
Diabetes Mellitus 32 (18,5%)
Preinterventional symptoms:
Fontaine I 1 (0,6%)
Fontaine II 125 (72,3%)
Fontaine III 17 (9,8%)
Fontaine IV 30 (17,3%)
TASC Classification:
A 26 (15,0%)
B 58 (33,5%)
C 18 (10,4%)
D 71 (41,0%)
Risk factor definitions:
SmokingZ active smoker or former smoker that stopped
smoking less than five years pre intervention.
HypertensionZ patients on antihypertensive medication or
BP> 140/90
DiabetesZ patients on antidiabetic medication (insulin and/or
oral medication)
Risk factors definitions: Smoking: active smoking and/or former
smoker that stopped smoking less than five years pre interven-
tion. Hypertension: patients on antihypertensive medication
and/or BP> 140/90. Diabetes: patients on insulin and/or oral
antidiabetic medication.
Table 3 Specification of kissingstents
Stent: N %
Self expanding: 88 50,9
Luminexx (Barda) 31
Memotherm (Barda) 19
Selfx (Abbotb) 21
Smart (Cordisc) 9
Other 8
Balloon expandable: 52 30,1
Jostent (Abbotb) 29
Express (Boston Scientificd) 4
Wavemax (Abbotb) 9
Palmaz (Cordisc) 5
Other ballonexp 5
Combinations:
(selfexp. and balloonexp.)
22 12,7
Luminexx 10
Memotherm 3
Selfx 8
Smart 1
Jostent 11
Jostentgraft 4
Express 3
Wavemax 4
Covered stents: 11 6,4
Jostentgraft (Abbotb) 11
Total: 173 100
The majority of the patients received self-expanding stents. All
patients that were treated with combinations received both
self-expanding and balloon expandable stents symmetrically
bilaterally, thus 22 patients received 44 stents in the aortic
bifurcation.
a www.bardnordic.com.
b www.abbotvascular.com.
c www.cordis.com.
d www.bostonscientific.com.
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access. 113 patients (65%) had bilateral lesions in the
common iliac arteries (CIA), of which 9 patients had
bilateral CIA occlusion. Thirty-eight patients (22%) were
stented in one or both of the external iliac arteries. Fifty
percent of the patients received self-expanding kissing-
stents. The distribution of stent types and brands are
presented in Table 3. The diameter of the kissingstents
varied from six to twelve mm, median was 10 mm. The
procedure was unsuccessful in one patient: the stents
occluded intraoperatively in a woman with cardiolipin
antibodies and she was treated with local trombolysis
12 hours, before successfully re-treated with kissing sten-
tgrafts. Two ruptures of the external iliac artery occurred
and were immediately sealed with covered stents. Other
complications are presented in Table 4.
Short term FU: first month
The patients had significantly (p< 0.0001) improved their
symptoms at first follow-up. 114 patients had improved
one Fontaine class and thirty-one patients two or more
classes. Twenty-four patients were unchanged. One
patient (with open stents) had developed a foot ulcer
caused by progressive distal atherosclerotic disease, and
transferred from Fontaine class III to IV. The mean ABIincreased significantly from 0.6 (SD 0.2) to 0.9 (SD 0.2),
p< 0.0001.
Two patients (1%) died within thirty days, one Fontaine
IV patient with severe gangrene in her legs died of sepsis
two days post intervention with patent kissingstents. The
other patient suffered from cardiac failure and died at
home twenty-four days after invention. The majority of
complications were mild and related to vascular access
(Table 4). Two Fontaine IV patients with large skin defects
and impaired distal circulation required unilateral lower
limb amputation within 30 days, both with patent suprain-
guinal stents.
FU first year
One patient was converted to aortobifemoral bypass
(41 days post intervention) due to rupture of the aortic
bifurcation with a slowly growing haematoma. During the
first year six patients had re-interventions. Two of them
were occlusions that required emergent re-intervention,
one with thrombectomy and re-stenting (hybrid treatment:
open exposure of CFA) and the other with thrombolysis and
Table 4 Per- and post interventional complications (0e30 days)
Complication n Comment or (%)
Minora:
Groin haematoma 11 Compression
Distal embolizations 3 2 not clinically significant, 1 successful aspiration
Renal embolization 1 Mild elevation of serum creatinine (not requiring dialysis)
Renal impairment (contrast) 1 Mild elevation of serum creatinine (not requiring dialysis)
EIA rupture 2 Immediately treated with covered stents
Summary: 18 (10%)
Majora:
Bleeding from puncture site 1 OR: raphi of CFA
Pseudo aneurysm in groin 1 OR: raphi of CFA
Rupture of aortic bifurcation 1 Slowly growing haematoma, conversion to ORb
Thrombosis 1 Thrombolysis (patient with coagulation disorder)
AMI (subendocardial) 1 No impaired cardiac function
Unspecific colon irritation 1 Abdominal pain after CO2 angiography, laparotomy but no bowel resection necessary.
c
Summary: 6 (3,5%)
a Complications are graded according to severity/outcome by Rutherford et al17.
b Patient converted to aortobifemoral bypass 41 days post intervention.
c Patient with renal insufficiency treated with CO2 angiography, and developed abdominal pain post intervention. Laparotomy
revealed unspecific non-ischemic irritation of colon, no bowel resection was performed, and the patient recovered completely.
Table 5 Life table analysis of the 173 patients treated
with kissingstents
Primary, Assisted and Secondary cumulative Patency
Months: No at
risk
Primary
Patency
Assisted
Patency
Secondary
Patency
12 135 0.97 0.99 1.00
24 92 0.88 0.94 0.97
36 62 0.83 0.90 0.95
48 39 0.74 0.83 0.91
60 21 0.65 0.73 0.83
428 K. Bjo¨rses et al.re-stenting. The remaining four re-interventions were
re-PTA and/or re-stenting with balloon expandable stents
or stentgrafts, due to re-stenosis diagnosed trough recur-
ring symptoms or decreased ABI on follow-up. One year
survival was 91%, 157 patients.
Long term FU ‡ one year
During the study period (mean 36 months) the total
mortality was 25% (43 patients). Cardiovascular disease
(AMI, cardiac failure) was the most frequent cause of
death, followed by malignancies. The mortality was signif-
icantly higher in patients in Fontaine class IV (p< 0.0001)
compared to the other Fontaine classes. TASC classification
did not affect mortality. During FU three more patients lost
one of their lower limbs because of impairment of distal
disease, they had all patent stents. Total amputation
frequency in the study was 3% (5 patients), providing 97%
limb salvage at three years.
Primary, assisted primary and secondary patency was
97%, 99%, 100% and 83%, 90%, 95% at 12 and 36 months
respectively. At five years the primary, assisted primary and
secondary patency was: 65%, 73% and 83%, however, there
were only 21 patients left at risk. (Table 5) There was no
statistically significant difference in primary, assisted
primary or secondary patency between the TASC classes
(Fig. 2).
During long term FU, eight patients developed re-
stenosis in the treated segments and were re-dilated or
re-stented. Twenty-two late occlusions occurred, of which
nine patients were successfully re-canalized and re-
stented. Four patients were treated with bypass surgery
because of stent occlusions; three patients received fem-
oro-femoral crossover bypasses and one woman with
bilateral stent occlusion received an aorto-bifemoral
bypass. The remaining nine occluded patients were not
re-vascularized due to limited symptoms or poor patientstatus. Due to progress of distal disease six patients
received distal bypasses during FU and four patients
underwent trombendarterectomy in CFA.
Uni- and multivariate analysis of factors presuming
affecting patency (Table 6) revealed only Fontaine Classifi-
cation as statistically significant. Patients with rest pain
(Fontaine III) had higher risk of re-stenosis or occlusions in
the treated region. CLI irrespective of symptoms did not,
however, affect patency, possible because of the high
mortality among the Fontaine IV patients.
Discussion
Mortality
The 30-day mortality of this study was 1% (2 patients). This
is well in comparison with previous studies of kissingstents
that report mortality of 0e2.3%.7,9,11e13,21 Kissingstent
treatment of AIOD reduces the 30-day mortality compared
to OR by 50%. The overall mortality in the study was 25%
(mean FU 3 years), which is high considering the mean
age of the patients was 64 years, and 70% were claudicants.
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Figure 2 Kaplan-Meier analysis of primary patency according
to TASC classification. There was no statistically significant
difference in primary patency between the different TASC
classes, here illustrated with TASC Aþ B compared to Cþ D.
(pZ 0.68, log rank).
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disease. The high mortality emphasizes the facts that
patients with peripheral vascular disease have a shorter
life expectancy, which is supported by Houston, et al.9
They present 38% mortality in ten years in a study where
90% of patients included were claudicants. This could
indeed be another argument for endovascular treatment;
these patients are probably at increased risk for advanced
surgery.
Complications
Most complications in endovascular treatment stem from
the puncture sites and are fairly mild. Uncomplicated groin
haematomas occurred in 6% of our patients, which is similar
to other series.7,8,12,13,15,16,22 Only two patients (1%)
required surgical treatment due to bleeding in our study.
A meticulous puncture technique, using fluoroscopy to
confirm a CFA position below the inguinal ligament and
above the femoral bifurcation is critical in avoiding
bleeding complications.23,24 Also the use of closure devices
probably reduces the risk of bleeding. In this study closure
devices were used more frequently in the later part of the
study interval, and almost all patients received manual
pressure at the puncture site and with a femo-stop device,
irrespective if closure device were used or not.
Major complications, such as vessel ruptures, distal
embolizations and thromboses, are usually immediately
solved with covered stents, aspiration and thrombolysis.
Conversions to OR are rare today. The frequency of major
complications, 2e5%8,13e16(in our cohort 3.5%) is also lower
compared to OR (8e13%).
Patency
The primary, assisted primary and secondary patency rates
were 83%, 90%, 95% and 65%, 73%, 83% at 36 and 60 months
respectively in our study. The patencyrates at five years
are, however, calculated on only 21 patients left at risk
(12%), since most of our patients were treated between2001e2004. Others have reported primary patency
between 58e86%6,12,16,22 at three years, and 81% and 68%
at five14 and ten9 years respectively. Secondary patency
rates are increased at over 90% at three years 15,16,22 and
93% and 86% at five 9,14 and ten years respectively.9 The
majority of the patients included in the above mentioned
studies were claudicants but also patients with CLI were
sometimes included. In our series 30% of the patients had
CLI. The patency for aortobifemoral bypass is reported at
85e89% at five years and 70e85% at ten years in claudicants
and 72e82% at five years and 61e76% at ten years in CLI
patients.5 The published five and ten year patency rates
of kissingstents are still based on very few patients
compared to series of OR, but the results are encouraging
and do not differ much from results after OR. The fact
that endovascular re-intervention is mostly much less trau-
matic than the equivalent open redo surgery makes the
secondary patency rates important.Patency affecting factors
There are studies in which kissingstent treatment of TASC C
and D have worse outcome,7,9,16 but they hold a limited
number of patients. In our study 50% of the patients were
TASC C and D, and we did not find any difference in
outcome compared to TASC A and B patients. With
increasing complexity of the lesions it is obviously more
challenging to treat the patients. The risk of vessel rupture
is higher in a heavily calcified aortic bifurcation or long
segment arterial recanalization, but even though this was
previously an indication for open conversion, these compli-
cations are now often solved with covered stent placement.
With modern stent materials and angioplasty balloons the
vast majority of the lesions are amenable to endovascular
repair, and with increasing experience the treatment is
becoming safer and smoother for both patient and
interventionist.
It has been discussed if stent types influence patency,
but there is no reported difference in the outcome of
kissingstents. We found no such difference in our series
either. 50% of our patients were treated with self-expanding
nitinol stents, which is our preference to use in longer
lesions when the vessels are tortuous. An over sizing of ten
to fifteen percent was common and all stents were post
dilated with kissing balloon technique. We use balloon
expandable stents in shorter and more calcified lesions
and to reinforce self-expanding stents if necessary. Only in
very calcified lesions with predicted high rupture risk do we
use covered stents primarily. The new pre-mounted balloon
expandable covered stents require smaller introducers than
their precursors, which make the intervention more
feasible. There are reports of primary treatment with
stentgrafts of iliac arteries,21,25 but only a few of the
patients received kissing stentgrafts. Primary results are
so far promising. The stentgrafts are, however, more expen-
sive than bare stents.
All of our kissingstents were placed with the proximal
ends parallel in the aorta. Some authors claim that crossing
of the proximal and ‘‘kissing’’ parts of the stents in the
aorta is consistent with decreased patency.8,16 The
anatomy of the aortic bifurcation, where the orifices of
Table 6 Uni and multivariate analysis of potential factors associated with patency
Factor N N RR p 95% CI RR p 95% CI
Pat Failureb Crude Crude Crude Adjusted Adjusted Adjusted
Age (interval):
30e50 22 13 2.12 0.08 0.91e4.91 1.94 0.15 0.79e4.77
51e60a 50 10 1 1 - 1 1 -
61e70 48 8 0.85 0.73 0.33e2.15 0.90 0.84 0.32e2.55
71e80 40 3 0.55 0.37 0.15e2.02 1.18 0.82 0.28e4.90
81e100 13 2 1.99 0.38 0.43e9.31 5.89 0.07 0.87e39.8
Gender:
Male 79 18 1.29 0.46 0.66e2.51 1.27 0.57 0.56e2.91
Femalea 94 18 1 - - 1 - -
Fontaine:
I 1 0 0 0.99 0 0 0.99 0
IIa 125 27 1 - - 1 - -
III 17 6 4.33 0.002 1.73e10.8 6.91 <0.0001 2.42e19.7
IV 30 3 0.88 0.84 0.26e2.95 0.88 0.85 0.22e3.43
TASC:
A 26 2 0.42 0.25 0.10e1.83 0.33 0.21 0.06e1.89
B 58 13 1.58 0.24 0.74e3.39 1.88 0.15 0.79e4.42
C 18 2 0.88 0.86 0.20e3.87 0.87 0.87 0.16e4.59
Da 71 19 1 - - 1 - -
Stent type:
Self expa 88 15 1 - - 1 - -
Balloon exp 52 11 1.05 0.91 0.47e2.35 1.27 0.60 0.51e3.13
Combination 22 8 2.32 0.06 0.98e5.52 2.26 0.10 0.87e5.91
Covered stents 11 2 1.50 0.59 0.34e6.69 2.94 0.20 0.57e15.1
Smoking:
Yes 101 29 1.75 0.19 0.76e4.05 2.16 0.18 0.71e6.56
Noa 60 7 1 - - 1 - -
Unknown 12 0 0 0.97 0 0 0.98 0
Total 173 36
(CrudeZ univariate analyse. AdjustedZmultivariate analyse.).
Cox regression analysis of potential factors associated with patency revealed only Fontaine III as a statistically significant factor for loss
of primary patency.
a Reference group.
b Failure: patients with stents not primary patent.
430 K. Bjo¨rses et al.the common iliac arteries are located at different levels
and also diverging, makes it difficult if not impossible to
avoid the stent crossing. For this reason we did not analyze
our angiographies for crossing of the kissingstents. Instead
we found an infrequent but interesting compression
phenomenon, where one of the kissingstents compresses
the other one and diminishes the lumen until unilateral
occlusion follows. This appears to occur even if the stents
are identical in make and size and deployed and dilated
simultaneously. The phenomenon is virtually undetectable
on a standard angiography but requires cross sectional
imaging and therefore we recommend a CT-angiography if
compression is suspected, so that steps can be taken for
its correction.
The severity of atherosclerotic disease and impaired
outflow might be important for patency. This is probably
reflected in our study by the influence of Fontaine class III
on patency. There were only 17 patients with restpain,
though. We could not find that CLI (including both Fontaine
III and IV patients) was associated with worse patency. This
could be masked by the high mortality we found among theFontaine IV patients. Leville et al, reports worse patency
for iliac stents in patients with CLI.4 Other authors have
reported that impaired distal run-off negatively affects
patency.3,26,27 Due to missing data, outflow scoring accord-
ing to the SVS-ISCVS standards17 was not possible in our
study, and thus could not be properly evaluated. We now
routinely use MRA in the workup of these patients and
future studies will be able to determine the role of distal
run-off in this setting.
Other studies have also implicated smoking,26 small
vessel size27 and young patients16 to decrease patency.
Unfortunately, the retrospective nature of our study limits
the ability to evaluate these factors definitely, although we
found no data to support any of these claims.
Conclusion
Endovascular treatment of AOID with kissing stents is
a convenient method of restoring circulation in the supra-
inguinal arteries, with low mortality, morbidity and with
good patencyrates irrespective of TASC classification.
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